Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy
Constantin‐Cristian Topriceanu(Barts Health NHS Trust), Carolyn Y. Ho(Brigham and Women's Hospital), James Moon(Virginia Mason Medical Center), Alexandre C. Pereira(University of Washington), Gabriella Captur(The Royal Free Hospital)
Cited by 87
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
|Circulation|2005|978
Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
|JACC. Cardiovascular imaging|2013|664